Articles tagged "Liver transplantation"

2019 American Transplant Congress
Aborted Live Donor Organ Recovery Procedures in the United States
M. Henderson, M. Waldram, A. Thomas, N. Desai, S. Ottman, J. Garonzik Wang, A. Massie, D. Segev, J. Bannon, F. Al Ammary, D. Brennan
Johns Hopkins, Baltimore, MD
*Purpose: Although live organ donation is a carefully and meticulously planned surgical procedure, live donor organ recovery procedures are occasionally aborted. These include procedures which…
2019 American Transplant Congress
Multimodal Analgesia Reduces Opioid Use after Liver Transplantation
K. Tong, W. Nolan, D. O'Sullivan, H. Kutzler
Hartford Hospital, Hartford, CT
*Purpose: The study aimed to determine if multi-modal pain management (MPM) can reduce opioid use in patients post-liver transplant.*Methods: This was a retrospective review of…
2019 American Transplant Congress
Correlations between Preoperative Hepatic Venous Pressure Gradient and Graft Hemodynamics after Reperfusion in Living Donor Liver Transplantation
H. Matsushima, M. Fujiki, K. Sasaki, F. Aucejo, T. Diago Uso, C. Kwon, B. Eghtesad, C. Miller, C. Quintini, K. Hashimoto
General Surgery, Digestive Disease & Surgery Institute, Cleveland Clinic, Cleveland Clinic, Cleveland, OH
*Purpose: Hepatic venous pressure gradient (HVPG) is known to correlate with severity of portal hypertension in patients with liver cirrhosis. We retrospectively investigated the clinical…
2019 American Transplant Congress
Patients With Persistently Low MELD-Na Scores Continue To Be At Risk Of Liver Related Death
N. Mazumder, K. Atiemo, S. Montag, A. Daud, A. Kho, M. Abecassis, J. Levitsky, D. Ladner
Northwestern Memorial Hospital, Chicago, IL
*Purpose: The Model for End Stage Liver Disease-Sodium (MELD-Na) score is a reliable predictor of 90-day mortality however its long term predictive ability is unclear,…
2019 American Transplant Congress
Metabolic Liver Transplant: A Single Cooperative 2002-2017
N. Yazigi¹, K. Chapman²
¹Transplantation, MedStar Georgetown University Hospital, Washigton, DC, ²Transplantation, Children's National Rare Disease Institute, Washington, DC
*Purpose: Liver transplant (LT) can increase quality and quantity of life for patients with inherited metabolic diseases (IMDs) who suffer severe and unpredictable complications despite…
2019 American Transplant Congress
Long Term Outcomes of Patients Transplanted for Hepatocellular Carcinoma with Human Immunodeficiency Virus Infection
R. Gedaly-Eidelman, E. Chacon, P. Eman, M. Gupta, J. Berger, A. El-Husseini, X. Mei, F. Marti, L. Turcios, M. Shah
University of Kentucky, Lexington, KY
*Purpose: Several studies have reported that HIV+ patients are 4-6 times more likely to develop HCC than uninfected individuals. Our aim was to assess outcomes…
2019 American Transplant Congress
Early Everolimus Conversion For Renal Protection In Liver Transplantation: The Sooner The Better?
M. Tomeczkowicz, N. Sulejmani, A. Jantz, B. Summers, T. Larson, R. Salgia
Henry Ford Health System, Detroit, MI
*Purpose: Calcineurin inhibitors (CNI) are the mainstay of immunosuppressive therapy in transplantation; however, a major side effect limiting CNI use is nephrotoxicity. Mammalian target of…
2019 American Transplant Congress
Pregnancy Outcomes by Conception Age in Female Liver Transplant Recipients
M. Sarkar¹, L. A. Coscia², D. Kliniewski², S. Rao³, S. Constantinescu⁴, M. J. Moritz⁵
¹Medicine, University of California San Francisco, San Francisco, CA, ²Gift of Life Institute, Transplant Pregnancy Registry International, Philadelphia, PA, ³Medicine, University of Virginia Health System, Charlottesville, VA, ⁴Lewis Katz School of Medicine, Temple University, Philadelphia, PA, ⁵Surgery, Lehigh Valley Health Network, Allentown, PA
*Purpose: The purpose of this study is to compare pregnancy outcomes in liver transplant recipients by different conception ages. Background: Over 30% of female transplant…
2019 American Transplant Congress
Barriers to Pre-Transplant Immunization: A Qualitative Study of Pediatric Liver-Transplant Stakeholders
A. G. Feldman¹, R. Marsh², A. Kempe³, M. Morris²
¹Pediatric Gastroenterology, Hepatology and Nutrition, University of Colorado, Aurora, CO, ²University of Colorado, Aurora, CO, ³Pediatrics, University of Colorado, Aurora, CO
*Purpose: Less than 30% of pediatric liver transplant recipients are up-to-date on age-appropriate immunizations at the time of transplant despite being at high-risk for infections…
2019 American Transplant Congress
Discovery and Validation of an Early Post-Transplant Biomarker Model Predictive of Chronic Kidney Disease in Liver Transplant Recipients
J. Levitsky¹, S. Asrani², G. Klintmalm², T. Schiano², A. Moss³, K. Chavin⁴, C. Miller⁵, L. Zhao⁶, K. Guo⁶, N. Bridges⁷, J. Odim⁷, M. Brown⁷, D. Ikle⁸, B. Armstrong⁸, M. Abecassis⁹
¹Gastroenterology and Hepatology, Northwestern University, Chicago, IL, ²Baylor, Dallas, TX, ³Mayo Arizona, Phoenix, AZ, ⁴Case Western, Cleveland, OH, ⁵Cleveland Clinic, Cleveland, OH, ⁶Northwestern University, Chicago, IL, ⁷NIAID, Bethesda, MD, ⁸Rho, Chapel Hill, NC, ⁹Comprehensive Transplant Center, Northwestern University, Chicago, IL
*Purpose: A significant proportion of patients develop chronic kidney disease after liver transplantation (LT). We aimed to develop clinical/protein models to predict future GFR deterioration…